Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Legal Cannabis In NJ: Is This Joint Worth A Quick $1 Billion?

Cannabis Could Cut New Jersey's Budget Gap Dramatically In First Year Says Law Firm Brach Eichler

 

ROSELAND, NJ - December 20, 2017 (Investorideas.com Newswire) Upon the release of its White Paper exploring what it calls "The most complex environment ever to legalize recreational cannabis use," lawyers at Brach Eichler observed that the initial organization of the industry could result in a windfall to the State exceeding $1 billion - before a single ounce is delivered.

The figure is based on the State creating an aggressive privatization of the industry in which large technology, testing, cultivation, transportation and other industry participants compete for roles and pay upfront licensing, franchising, and other fees.

"The State needs $3 billion to close its budget gap and it so far has identified cannabis as contributing $300 million from sales tax," says John D. Fanburg, Managing Member and Chair of the Health Law Practice at Brach Eichler. "Presumptively, if there is a $2 billion recreational cannabis market in New Jersey, privatized functions could be offered in RFPs that provide lengthy contracts - the type that attract investors who pay-up for predictable returns. A billion dollars is probably a modest estimate of the opportunity New Jersey can potentially realize as it legalizes recreational cannabis."

The White Paper, The Business, Regulatory and Legal Challenges - and Opportunity -of Legalized Cannabis in New Jersey, which explores the differences between New Jersey's presumed recreational cannabis legalization versus circumstances in states with existing programs, warns that "New Jersey holds complexities not faced by other states unrelated to the production, distribution, sale, and use of marijuana, but attributed to a simple fact of life: this is New Jersey, and almost everything is harder here."

"Home rule is the principal culprit," says Charles X. Gormally, Member and Chair of the Litigation Practice for Brach Eichler. "It's the third rail of New Jersey politics, so great care will be taken to protect the will of municipalities in drafting the Cannabis Statute.

"Part of the social justice initiative will be to provide economic opportunities in urban communities, which will be very appealing to some municipalities. However, it's inevitable that there will be great tension between local officials and regulators about who gets what part of the pie - and why."

The White Paper observes solutions developed in other states around not only Industry Structure, but a variety of oversight, taxation, and participation issues, including sections on Home Rule, Property Taxes, Delivery, Banking, Commerce, Public Health, Testing Product Safety, Regulatory Authority, Criminality, and Cannabis as Tourism. While the Administration has not indicated any specific direction on any of the issues broached in the White Paper, Mr. Gormally says it will be "unavoidable" that fiscal issues dominate the dialogue.

"The ultimate social justice would be to immediately decriminalize possession, but that does not provide the long-term political leverage that will lead to a healthy industry and a leveraging of the state's interests. You have a lot of smart people in the incoming Administration who have already seen that current legislative proposals will not generate the $300 million they already have allocated to programs they are committed to enact immediately.

"At the edges of this industry you have a black-market cohort that wants to legitimize its crop and reduce the risks of its current distribution program; and another cohort with access to a massive pool of capital if margins are protected," says Mr. Fanburg. "In the middle is a new administration desperate to lead the State back to economic relevance and a legislature determined to protect programs that are threatened by fiscal realities. So, while it is unlikely that the state goes all the way and monetizes every component of the industry, as they start to tinker with a new Statute, the opportunity to generate upfront cash will prove at least partially irresistible."

Click here to learn more about Brach Eichler's Cannabis Practice and its White Paper, The Business, Regulatory and Legal Challenges - and Opportunity - of Legalized Cannabis in New Jersey.

About Brach Eichler

Brach Eichler LLC is a full-service law firm based in Roseland, N.J. With over 70 attorneys, the firm is focused in the following practice areas: Cannabis, Health Law, Real Estate, Litigation, Trusts & Estates, Business Transactions & Financial Services, Personal Injury, Criminal Defense and Government Investigations, Labor and Employment, Environmental & Land Use, Family Law, Patent, Intellectual Property & Information Technology, Real Estate Tax Appeals, and Tax. Brach Eichler attorneys have been recognized by clients and peers alike in Best Lawyers in America, Chambers USA, and New Jersey Super Lawyers. Visit www.bracheichler.com for a copy of the White Paper.



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp